Skip to main content
Results of phase 2 trial of eritoram, a synthetic TLR-4 antagonist, in patients with severe sepsis
All Scholarly Works
  • Mark Tidswell, MD, Baystate Health
Document Type
Presentations, Research
Publication Date
Citation Information
Society of Critical Care Medicine 36th Critical Care Congress 2007 Feb. Crit Care Med 2006;34:7.